Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Long-term outcomes of patients with mucopolysaccharidosis VI treated with galsulfase enzyme replacement therapy since infancy.
Journal: Molecular genetics and metabolism
Published: January 15, 2021
A Rare Cause of Shock in an Infant: Cor Triatriatum.
Journal: Pediatric emergency care
Published: May 03, 2017
Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.
Journal: Annals of hematology
Published: December 20, 2013
Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy.
Journal: Journal of inherited metabolic disease
Published: October 17, 2011
Showing 1-4 of 4
Last Updated: 09/26/2026